Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppression--an overview

E Miller1

  • 1Colorado State University, College of Veterinary Medicine and Biomedical Sciences, Department of Clinical Sciences, Fort Collins, USA.

Seminars in Veterinary Medicine and Surgery (Small Animal)
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.

Archives of disease in childhood. Fetal and neonatal edition·2004
Same author

Anencephaly-something missing from the archaeological record?

Paleopathology newsletter·2003
Same author

Sero-epidemiology of mumps in western Europe.

Epidemiology and infection·2003
Same author

Severe and unrecognised: pertussis in UK infants.

Archives of disease in childhood·2003
Same author

Measurement and interpretation of pneumococcal IgG levels for clinical management.

Clinical and experimental immunology·2003
Same author

Nutrient removal from wastewaters using high performance materials.

Water science and technology : a journal of the International Association on Water Pollution Research·2003
Same journal

Diagnosis and treatment of gastrinoma.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Transplantation for the treatment of diabetes mellitus.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Complications and concurrent disease associated with diabetes mellitus.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Oral hypoglycemic agents for noninsulin-dependent diabetes mellitus in the cat.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Management of the uncomplicated canine diabetic.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Diabetic ketoacidosis.

Seminars in veterinary medicine and surgery (small animal)·2000
See all related articles

Effective immunosuppressive therapy for immune-mediated diseases in pets is challenging. Current treatments use combinations of drugs, but ideal therapies that selectively target abnormal immune responses are still needed.

Area of Science:

  • Veterinary Immunology
  • Immunosuppressive Therapy

Background:

  • Immune-mediated diseases in dogs and cats necessitate effective immunosuppression.
  • Current therapies struggle to selectively suppress anti-self immunity while preserving anti-pathogen responses.

Purpose of the Study:

  • To review current immunosuppressive therapies for immune-mediated diseases in companion animals.
  • To discuss the mechanisms of action for existing and emerging immunosuppressive agents.

Main Methods:

  • Review of established and novel immunosuppressive agents.
  • Discussion of glucocorticoids, cytotoxic drugs (cyclophosphamide, azathioprine), cyclosporine A, and androgens.
  • Exploration of newer agents targeting nucleotide synthesis or lymphocyte signaling.

Related Experiment Videos

Main Results:

  • Glucocorticoids offer broad anti-inflammatory and immunosuppressive effects.
  • Cytotoxic drugs inhibit immune cell proliferation and antibody synthesis.
  • Cyclosporine A targets interleukin-2 production, crucial for lymphocyte activation.

Conclusions:

  • Current immunosuppressive strategies involve drug combinations with varied mechanisms.
  • Emerging agents offer targeted approaches to modulate lymphocyte function.
  • Further research is needed for ideal therapies with selective immunosuppression.